Table 4.
Multiple logistic regression analysis for MetS and insulin resistance
| Characteristics | MetS adjusted OR (95 % CI) | Insulin resistancea adjusted OR (95 % CI) | ||||
|---|---|---|---|---|---|---|
| hsCRP-1st | hsCRP-2nd | hsCRP-3rd | hsCRP-1st | hsCRP-2nd | hsCRP-3rd | |
| Uric acid-1st | Reference | 1.26 (0.57–2.87) | 3.31 (1.51–7.24) | Reference | 1.22 (0.52–2.87) | 1.48 (0.58–3.80) |
| Uric acid-2nd | 1.93 (0.87–4.30) | 3.31 (1.64–6.68) | 3.89 (1.89–8.01) | 1.70 (0.72–4.01) | 1.91 (0.87–4.19) | 3.56 (1.68–7.58) |
| Uric acid-3rd | 3.36 (1.52–7.43) | 4.35 (2.11–8.99) | 9.25 (4.81–17.8) | 3.11 (1.34–7.21) | 3.60 (1.66–7.77) | 8.92 (4.54–17.6) |
Metabolic syndrome (MetS) was defined as having three or more of the following conditions: obesity, raised blood pressure, hypertriglyceridemia, low HDL cholesterolemia, and impaired fasting plasma glucose. Adjusted for the following parameters: age, current smoking status, and alcohol consumption
aInsulin resistance was defined as HOMA-IR ≥2.6